221 related articles for article (PubMed ID: 16718271)
21. Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study.
Pföhler C; Cree IA; Ugurel S; Kuwert C; Haass N; Neuber K; Hengge U; Corrie PG; Zutt M; Tilgen W; Reinhold U
Anticancer Drugs; 2003 Jun; 14(5):337-40. PubMed ID: 12782938
[TBL] [Abstract][Full Text] [Related]
22. A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma.
Schmittel A; Schmidt-Hieber M; Martus P; Bechrakis NE; Schuster R; Siehl JM; Foerster MH; Thiel E; Keilholz U
Ann Oncol; 2006 Dec; 17(12):1826-9. PubMed ID: 16971664
[TBL] [Abstract][Full Text] [Related]
23. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen.
Cocconi G; Bella M; Calabresi F; Tonato M; Canaletti R; Boni C; Buzzi F; Ceci G; Corgna E; Costa P
N Engl J Med; 1992 Aug; 327(8):516-23. PubMed ID: 1635566
[TBL] [Abstract][Full Text] [Related]
24. Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma.
Weber JS; Zarour H; Redman B; Trefzer U; O'Day S; van den Eertwegh AJ; Marshall E; Wagner S
Cancer; 2009 Sep; 115(17):3944-54. PubMed ID: 19536884
[TBL] [Abstract][Full Text] [Related]
25. Uveal melanoma: natural history and treatment options for metastatic disease.
Wöll E; Bedikian A; Legha SS
Melanoma Res; 1999 Dec; 9(6):575-81. PubMed ID: 10661768
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients.
Atzpodien J; Terfloth K; Fluck M; Reitz M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):685-8. PubMed ID: 18084763
[TBL] [Abstract][Full Text] [Related]
27. Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma.
Kivelä T; Suciu S; Hansson J; Kruit WH; Vuoristo MS; Kloke O; Gore M; Hahka-Kemppinen M; Parvinen LM; Kumpulainen E; Humblet Y; Pyrhönen S
Eur J Cancer; 2003 May; 39(8):1115-20. PubMed ID: 12736111
[TBL] [Abstract][Full Text] [Related]
28. Single-dose dacarbazine and dactinomycin in advanced malignant melanoma.
Hochster H; Levin M; Speyer J; Dunleavy S; Harris M; Roses D; Golomb F; Muggia F
Cancer Treat Rep; 1985 Jan; 69(1):39-42. PubMed ID: 3967259
[TBL] [Abstract][Full Text] [Related]
29. Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2.
Becker JC; Terheyden P; Kämpgen E; Wagner S; Neumann C; Schadendorf D; Steinmann A; Wittenberg G; Lieb W; Bröcker EB
Br J Cancer; 2002 Oct; 87(8):840-5. PubMed ID: 12373596
[TBL] [Abstract][Full Text] [Related]
30. Selumetinib shows promise in metastatic uveal melanoma.
Cancer Discov; 2013 Jul; 3(7):OF8. PubMed ID: 23847383
[TBL] [Abstract][Full Text] [Related]
31. Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma.
Schmittel A; Scheulen ME; Bechrakis NE; Strumberg D; Baumgart J; Bornfeld N; Foerster MH; Thiel E; Keilholz U
Melanoma Res; 2005 Jun; 15(3):205-7. PubMed ID: 15917703
[TBL] [Abstract][Full Text] [Related]
32. Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study.
Neri B; Vannozzi L; Fulignati C; Pantaleo P; Pantalone D; Paoletti C; Perfetto F; Turrini M; Mazzanti R
Cancer Invest; 2006; 24(5):474-8. PubMed ID: 16939954
[TBL] [Abstract][Full Text] [Related]
33. Melanoma inhibitory activity: a novel serum marker for uveal melanoma.
Schaller UC; Bosserhoff AK; Neubauer AS; Buettner R; Kampik A; Mueller AJ
Melanoma Res; 2002 Dec; 12(6):593-9. PubMed ID: 12459649
[TBL] [Abstract][Full Text] [Related]
34. A pilot study with vincristine sulfate liposome infusion in patients with metastatic melanoma.
Bedikian AY; Papadopoulos NE; Kim KB; Vardeleon A; Smith T; Lu B; Deitcher SR
Melanoma Res; 2008 Dec; 18(6):400-4. PubMed ID: 19011511
[TBL] [Abstract][Full Text] [Related]
35. Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation.
Al-Jamal RT; Eskelin S; Pyrhönen S; Kivelä T
Acta Oncol; 2009; 48(3):476-9. PubMed ID: 19031163
[No Abstract] [Full Text] [Related]
36. Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: a single institution phase II study.
Schinzari G; Rossi E; Cassano A; Dadduzio V; Quirino M; Pagliara M; Blasi MA; Barone C
Melanoma Res; 2017 Dec; 27(6):591-595. PubMed ID: 29076951
[TBL] [Abstract][Full Text] [Related]
37. Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.
Lewis KD; Robinson WA; McCarter M; Pearlman N; O'Day SJ; Anderson C; Amatruda TT; Baron A; Zeng C; Becker M; Dollarhide S; Matijevich K; Gonzalez R
J Clin Oncol; 2006 Jul; 24(19):3157-63. PubMed ID: 16809738
[TBL] [Abstract][Full Text] [Related]
38. Combination chemotherapy with dacarbazine and vindesine in the treatment of metastatic malignant melanoma.
Vorobiof DA; Sarli R; Falkson G
Cancer Treat Rep; 1986 Jul; 70(7):927-8. PubMed ID: 3719588
[No Abstract] [Full Text] [Related]
39. BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy.
Nathan FE; Berd D; Sato T; Shield JA; Shields CL; De Potter P; Mastrangelo MJ
J Exp Clin Cancer Res; 1997 Jun; 16(2):201-8. PubMed ID: 9261748
[TBL] [Abstract][Full Text] [Related]
40. Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201).
Luke JJ; Olson DJ; Allred JB; Strand CA; Bao R; Zha Y; Carll T; Labadie BW; Bastos BR; Butler MO; Hogg D; Munster PN; Schwartz GK
Clin Cancer Res; 2020 Feb; 26(4):804-811. PubMed ID: 31558480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
